Tag Archives: Medicare

Does Pharma Have a Debt Crisis Strategy?

By William Looney and Ben Comer | Published: July 20, 2011

The Obama Administration’s proposed fiscal budget for 2012 suggested that all bets are off for biopharmaceutical revenue safeguards, but it never had a chance with Congress, as evidenced by a unanimous no-thank-you from the Senate in late May. But that was before debt ceiling talks and the alleged possibility of a default emerged as the [...]

Posted in Corporate Responsibility, Europe, Global, Strategy, healthcare, leadership, pricing | Also tagged Barack Obama, deficit, Medicaid, policy, Politics | 1 Comment

IPAB : An HCR Acronym You Need to Understand

By Guest Blogger | Published: June 1, 2011

Tom Norton throws some light on the much-vaunted Independent Payment Advisory Board. Working towards our top issue for the June edition of the HCR Monthly Review, I continue to be struck by the amount of macroeconomic data that will be driving the new HCR law. Indeed, most of the key performance measures in the 2010 statute [...]

Posted in Regulatory, healthcare | Also tagged HCR, healthcare reform, Independent Payment Advisory Board, IPAB, Medicaid, NICE | 2 Comments

More States Follow Washington's Value-Based Lead

By Guest Blogger | Published: April 22, 2011

Cameron McClearn looks at how Washington State’s approach to health care value is beginning to influence the rest of the country. Many trends start on the West Coast and migrate to the rest of the nation. The Washington State health care system is worth watching as officials evaluate the economic value of medical treatments for state [...]

Posted in healthcare, pricing | Also tagged evidenced-based rationing, health economics, HTA, Medicaid, value, value-based | 2 Comments

Another Big Run on Pharma's Bank Account

By Ben Comer | Published: April 19, 2011

What exactly did that $80 billion deposit for health reform buy? Lots of industry CEOs traveled to the White House and shook hands with President Obama during the spring and summer of 2009, and while the specifics of those conversations haven’t been made public, the result was industry support of healthcare reform, and a pledge of [...]

Posted in Regulatory, healthcare | Also tagged CMS, Health Reform, Medicaid, Obama, Patient Protection and Affordable Care Act, PhRMA | 2 Comments

Inspector General Puts Forest CEO in the Crosshairs

By Ben Comer | Published: April 15, 2011

Forest Laboratories’ CEO Howard Solomon was no doubt surprised to receive a form letter from the Office of Inspector General (OIG) on April 8, which, if acted upon, would exclude him from doing business with federal healthcare plans, including Medicare and Medicaid. Solomon has 30 days to explain to the OIG why he should not be [...]

Posted in Strategy | Also tagged Celexa, Forest Laboratories, Howard Solomon, Levothroid, Lexapro, Medicaid, Office of Inspector General | Leave a comment